An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia
- 1 October 2015
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 28 (2) , 897-900
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Understanding the Immunodeficiency in Chronic Lymphocytic LeukemiaHematology/Oncology Clinics of North America, 2013
- The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemiaHaematologica, 2013
- Lymphoid malignancies: many tumor types, many altered genes, many therapeutic challengesJournal of Clinical Investigation, 2012
- Molecular pathogenesis of chronic lymphocytic leukemiaJournal of Clinical Investigation, 2012
- Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease ProgressionClinical Cancer Research, 2012
- Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilitiesBlood, 2011
- Prognostic Markers and Stratification of Chronic Lymphocytic LeukemiaHematology-American Society Hematology Education Program, 2010
- The clinical application of monoclonal antibodies in chronic lymphocytic leukemiaBlood, 2010
- Reference values for B cell subpopulations from infancy to adulthoodClinical and Experimental Immunology, 2010
- The pathology of the chronic lymphoid leukaemiasBlood Reviews, 1995